Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 2
1994 1
1996 4
1997 3
1998 1
1999 3
2000 4
2001 5
2003 3
2006 2
2007 7
2008 4
2009 2
2010 1
2011 1
2012 4
2013 2
2014 5
2015 2
2016 3
2017 3
2018 2
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A. Tumeh PC, et al. Among authors: tomasic g. Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954. Nature. 2014. PMID: 25428505 Free PMC article. Clinical Trial.
Predictors of responses to immune checkpoint blockade in advanced melanoma.
Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Ternès N, Jegou S, Woods DM, Sodré AL, Hansen M, Meirow Y, Sade-Feldman M, Burra A, Kwek SS, Flament C, Messaoudene M, Duong CPM, Chen L, Kwon BS, Anderson AC, Kuchroo VK, Weide B, Aubin F, Borg C, Dalle S, Beatrix O, Ayyoub M, Balme B, Tomasic G, Di Giacomo AM, Maio M, Schadendorf D, Melero I, Dréno B, Khammari A, Dummer R, Levesque M, Koguchi Y, Fong L, Lotem M, Baniyash M, Schmidt H, Svane IM, Kroemer G, Marabelle A, Michiels S, Cavalcanti A, Smyth MJ, Weber JS, Eggermont AM, Zitvogel L. Jacquelot N, et al. Among authors: tomasic g. Nat Commun. 2017 Sep 19;8(1):592. doi: 10.1038/s41467-017-00608-2. Nat Commun. 2017. PMID: 28928380 Free PMC article.
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L, Malka-Mahieu H, Girault I, Allard D, Hemmingsson O, Tomasic G, Thomas M, Basmadjian C, Ribeiro N, Thuaud F, Mateus C, Routier E, Kamsu-Kom N, Agoussi S, Eggermont AM, Désaubry L, Robert C, Vagner S. Boussemart L, et al. Among authors: tomasic g. Nature. 2014 Sep 4;513(7516):105-9. doi: 10.1038/nature13572. Epub 2014 Jul 27. Nature. 2014. PMID: 25079330
Generalised morphea induced by pembrolizumab.
Herrscher H, Tomasic G, Castro Gordon A. Herrscher H, et al. Among authors: tomasic g. Eur J Cancer. 2019 Jul;116:178-181. doi: 10.1016/j.ejca.2019.05.018. Epub 2019 Jun 12. Eur J Cancer. 2019. PMID: 31202088 No abstract available.
[Management of patients with melanoma].
Robert C, Cavalcanti A, Kolb F, Sarfati B, Moya-Plana A, Tomasic G, Mateus C. Robert C, et al. Among authors: tomasic g. Rev Prat. 2014 Jan;64(1):75-80. Rev Prat. 2014. PMID: 24649552 Review. French.
Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.
Verver D, Poirier-Colame V, Tomasic G, Cherif-Rebai K, Grunhagen DJ, Verhoef C, Suciu S, Robert C, Zitvogel L, Eggermont AMM. Verver D, et al. Among authors: tomasic g. Oncoimmunology. 2019 Sep 6;8(11):e1660121. doi: 10.1080/2162402X.2019.1660121. eCollection 2019. Oncoimmunology. 2019. PMID: 31646109 Free PMC article.
Vemurafenib and radiosensitization.
Boussemart L, Boivin C, Claveau J, Tao YG, Tomasic G, Routier E, Mateus C, Deutsch E, Robert C. Boussemart L, et al. Among authors: tomasic g. JAMA Dermatol. 2013 Jul;149(7):855-7. doi: 10.1001/jamadermatol.2013.4200. JAMA Dermatol. 2013. PMID: 23699661
Sentinel lymph node biopsy in cutaneous head and neck melanoma.
Evrard D, Routier E, Mateus C, Tomasic G, Lombroso J, Kolb F, Robert C, Moya-Plana A. Evrard D, et al. Among authors: tomasic g. Eur Arch Otorhinolaryngol. 2018 May;275(5):1271-1279. doi: 10.1007/s00405-018-4934-3. Epub 2018 Mar 19. Eur Arch Otorhinolaryngol. 2018. PMID: 29552728
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page